Asma - Aula de Pneumologia do Curso Intensivo Residência Médica

Name: Asma - Aula de Pneumologia do Curso Intensivo Residência Médica
Uploaded: 2024-06-22T11:45:40.000Z
Duration: 2 h 48 min 56 s

Special Offer on Medical Courses

Overview of the Course Promotion

The R+ Clínica Médica from Estratégia M is offering a special promotion with a 40% discount on their courses, including R+ Turbo and Prime Class.

The courses are designed to provide comprehensive material focused entirely on the ENARI exam for clinical specialties, eliminating the need for external resources.

Course Content and Structure

The content for R+ Turbo and Prime Class has been developed by expert instructors, ensuring that students study essential topics that are frequently tested by the new examination board (AF FGV).

Students will have access to Sprint R+ Clínica Médica ENARI, which includes 500 unique questions with detailed solutions available in both text and video formats.

Additional Resources and Benefits

Exclusive video lessons are provided to help students review critical topics just before their exams, along with strategic summaries of important clinical medicine concepts.

A vast question bank containing over 65,000 clinical medicine questions is available for students to reinforce their knowledge through practice and expert commentary.

Friday Medical Clinic Sessions

Weekly Discussions on Clinical Topics

Every Friday at 7 PM, Estratégia M hosts discussions related to clinical medicine on YouTube. Today's focus is on bronchial asthma, a key topic often featured in exams.

Engaging with Current Literature

The session aims to explore recent updates in asthma management based on the latest GINA document published in 2024.

Upcoming Educational Opportunities

Introduction to Intensive Course on Bronchial Asthma

Overview of the Course

The session is part of an intensive course aimed at providing direct and focused content for students preparing for medical exams.

Emphasis is placed on efficient study material due to limited time before upcoming exams, encouraging students to concentrate their efforts.

Announcement of a mid-year course launch on July 1st, offering special pricing for various medical training products.

Engagement and Notifications

Students are encouraged to engage with the live session by liking the video, subscribing, and activating notifications for future events.

Mention of concurrent live events related to practical exams and bronchial asthma discussions, highlighting the relevance of these topics in medical assessments.

Understanding Bronchial Asthma

Introduction to the Topic

The instructor introduces himself as Rander Molinari, a Clinical Medicine professor, ready to guide through key aspects of bronchial asthma.

Acknowledgment that bronchial asthma is one of the most significant topics in pulmonology relevant for residency examinations.

Key Concepts in Asthma Management

Focus will be on critical areas such as maintenance treatment options, medication adjustments (increase/decrease), and exacerbation management—key themes frequently tested in exams.

Pathophysiology and Diagnosis

Characteristics of Asthma

Asthma is described as a heterogeneous obstructive ventilatory disorder with various subtypes including allergic and non-allergic forms.

Chronic inflammation of airways is identified as a common feature across all asthma types.

Diagnostic Approach

Variable airflow limitation characterizes asthma; symptoms can fluctuate between periods of exacerbation and resolution.

Diagnosis primarily relies on clinical evaluation but spirometry can aid when available; it’s not always necessary but beneficial when suspected.

Clinical Associations

Atopy Connection

Understanding Bronchial Asthma

Pathophysiology of Asthma

The pathophysiological mechanism of asthma involves a reduction in airway caliber, leading to an obstructive ventilatory disorder characterized by bronchial hyperresponsiveness.

In asthmatic patients, the airways are inflamed, causing repeated cycles of inflammation and resolution that eventually lead to airway remodeling.

Airway remodeling results in structural changes such as thickening of the bronchial walls, which can cause fixed airflow obstruction similar to chronic obstructive pulmonary disease (COPD).

The goal of asthma treatment is to prevent this remodeling process from occurring, thereby maintaining normal airway structure and function.

Phenotypes of Asthma

Asthma is heterogeneous with various phenotypes; allergic asthma is the most common and often associated with eosinophilic inflammation.

Non-allergic asthma lacks atopy and typically requires higher doses of corticosteroids due to poor response.

Late-onset asthma occurs in adulthood with fixed airflow limitation and may show negative bronchodilator responses on spirometry.

Obesity-related asthma presents with fewer eosinophils and reduced response to inhaled corticosteroids.

Symptoms Indicating Suspected Asthma

Four cardinal symptoms suggestive of bronchial asthma include dyspnea, wheezing, chest tightness, and cough.

Dyspnea is prevalent across many respiratory conditions; wheezing indicates narrowed airways during auscultation.

A critical sign during severe exacerbations can be "silent chest," where minimal or no breath sounds indicate severe airflow obstruction—this is a medical emergency.

Triggers and Diagnosis

Symptoms often worsen at night or early morning; triggers include physical exertion, allergens like dust mites or pet dander, cold air, and viral infections.

Diagnosis relies primarily on clinical evaluation based on symptoms but should ideally be supported by spirometry for confirmation and severity assessment.

Importance of Spirometry

While diagnosis can be clinical, spirometry plays a crucial role in confirming diagnosis and assessing disease severity for appropriate treatment planning.

It’s important to note that spirometry may yield normal results during asymptomatic periods in intermittent cases; thus clinical correlation remains essential.

Understanding Asthma Diagnosis and Spirometry

Overview of Spirometry in Asthma Diagnosis

A normal spirometry result does not rule out asthma; clinical symptoms are crucial for diagnosis.

The most common expectation in spirometry is an obstructive ventilatory disorder with a positive bronchodilator response.

An obstructive ventilatory disorder is indicated by a forced expiratory volume (FEV1) to forced vital capacity (FVC) ratio less than 0.7, which can suggest conditions like asthma or COPD.

Key Parameters in Asthma Assessment

Asthma typically shows good response to bronchodilators, characterized by variable airflow limitation.

A positive bronchodilator response is defined as an increase of at least 200 ml or 12% from the baseline FEV1 after administration of a bronchodilator.

In asthmatic patients, FEV1 decreases while FVC may also decrease, leading to a reduced FEV1/FVC ratio.

Understanding Flow Rates and Patterns

Patients with obstructive disorders struggle to expel air quickly, resulting in lower peak flow rates and prolonged expiration times.

The peak expiratory flow rate (PEFR) curve will show diminished peaks due to airflow obstruction during exhalation.

Additional Diagnostic Tools

Peak flow meters are simple devices that can be used for monitoring respiratory function and are more accessible than spirometers.

Patients can use peak flow meters at home to track their symptoms and variability in lung function over time.

Variability Indicators for Asthma

Significant variability in peak flow readings correlates with asthma; measurements taken during symptomatic periods provide valuable diagnostic information.

According to GINA guidelines, if spirometry isn't available but there’s a ≥20% increase in PEFR post-bronchodilator, it supports an asthma diagnosis.

Monitoring changes in PEFR over two weeks can indicate variable airflow limitation characteristic of asthma.

Understanding Occupational Asthma

Socioeconomic Differences and Spirometry Availability

There are significant socioeconomic differences affecting the availability of spirometry; in some places, it is scarce.

While cough and chest tightness are symptoms of asthma, redness (ridão) is not a direct symptom but can occur due to inhaled corticosteroids.

Special Situations in Asthma Diagnosis

A patient reports shortness of breath and wheezing that only occurs during weekdays at work, suggesting a potential occupational asthma diagnosis.

Occupational exposure can lead to respiratory symptoms that mimic asthma but may not be classified as such; for example, pneumoconiosis from asbestos exposure.

Types of Work-related Asthma

There are two types of work-related asthma: aggravated asthma (existing condition worsened by work environment) and occupational asthma (new onset due to workplace exposure).

Aggravated asthma refers to worsening symptoms in someone already diagnosed with asthma after starting a new job.

Mechanisms Behind Occupational Asthma

Occupational asthma can arise from sensitivity or irritants; for instance, chemical exposure may cause airway irritation leading to bronchial asthma.

Symptoms often worsen during working hours, prompting suspicion of occupational factors contributing to the patient's condition.

Diagnostic Approaches for Work-related Asthma

Measuring peak expiratory flow rate at home versus work helps diagnose occupational asthma; a drop greater than 30% indicates work-related issues.

Case Study: Diagnosing Occupational Asthma

A 25-year-old hairdresser experiences significant variability in peak flow readings while at work compared to when she is away from it, confirming an occupational link.

Conclusion and Next Steps

Important Announcements and Course Details

Engagement and Subscription Reminder

The speaker emphasizes the importance of liking the video, subscribing to the channel, and activating notifications to support ongoing free content production.

Upcoming Live Event

An invitation is extended to join a live launch event for a mid-year course on July 1st, highlighting it as an opportunity to secure desired products from the educational platform.

Transitioning to Block Two

The speaker prepares for Block Two of the session, indicating that important information will be shared shortly after addressing audience questions.

Discussion on Practical Courses

Mention of fully booked practical courses in São Paulo for students preparing for revalidation exams, emphasizing personal interaction with diverse participants from various countries.

Understanding Asthma Control

Introduction to Block Two

The speaker introduces themselves as Rander Molinari, a Clinical Medicine professor, and sets expectations for Block Two focused on bronchial asthma.

Key Concepts: Control vs. Severity

A critical distinction is made between 'control' and 'severity' of asthma; control refers to management effectiveness while severity indicates underlying disease intensity.

Parameters for Assessing Asthma Control

Four clinical parameters are essential in evaluating asthma control:

Nighttime awakenings

Activity limitations

Daytime symptoms

Use of rescue medications

Mnemonic for Remembering Parameters

The mnemonic "delícia" (with an emphasis on Portuguese spelling) helps recall these parameters effectively during assessments or examinations.

Classification Based on Control Levels

Patients are classified based on their responses:

Controlled: No issues with any parameter.

Partially controlled: One or two issues present.

Understanding Asthma Control and Treatment

Classification of Asthma Control

Asthma is classified as uncontrolled if the patient has experienced an exacerbation in the last month, regardless of other factors.

Patients using relief medication solely for exercise do not count as having uncontrolled asthma; this is considered prophylactic use rather than symptomatic relief.

A case study discusses a woman with childhood asthma who uses salbutamol only during crises (1-2 times a month), indicating controlled asthma due to lack of nighttime awakenings and normal daily activities.

Maintenance Treatment Overview

The discussion transitions to maintenance treatment, emphasizing the importance of understanding different medication classes: LABA, LAMA, SABA, and SAMAs.

Short-acting beta agonists (SABAs), such as fenoterol and salbutamol, are highlighted alongside long-acting beta agonists (LABAs), including formoterol and salmeterol.

Inhaled Corticosteroids (ICS)

Inhaled corticosteroids like budesonide and fluticasone are essential in asthma management; specific dosages should be memorized for exams.

Budesonide dosing is categorized into low (<400 mcg/day), moderate (400–800 mcg/day), and high (>800 mcg/day); these distinctions are crucial for treatment planning.

Importance of Inhaled Corticosteroids

It’s emphasized that no maintenance treatment for asthma can exclude inhaled corticosteroids due to their anti-inflammatory properties necessary for managing chronic inflammation in asthma patients.

Treatment Steps in Asthma Management

The treatment approach involves assessing symptom control over time; if well-controlled for over three months, a step-down approach may be taken. Conversely, if poorly controlled, a step-up strategy is recommended.

Preferred vs. Alternative Treatment Pathways

There are two pathways in asthma treatment: preferred (ideal medications that provide optimal care) and alternative (used when preferred options are unavailable).

Formoterol: A Dual-Action Medication

Overview of Formoterol

Formoterol is a long-acting beta agonist (LABA) known for its prolonged duration, making it ideal for maintenance therapy in asthma management.

It acts quickly, providing relief from symptoms in under 5 minutes, which makes it effective for both maintenance and acute symptom relief.

Patients are advised to use formoterol daily for maintenance and as needed for symptom relief, simplifying asthma management.

Treatment Steps with Formoterol

In the first two steps of treatment, the combination of inhaled corticosteroids and formoterol is emphasized; patients should use this combination during symptomatic episodes.

If a patient remains uncontrolled despite using this regimen, they may progress to step three where formoterol is used more regularly.

Escalation of Therapy

When transitioning from step one or two to step three due to inadequate control, the recommendation is to increase the frequency of formoterol usage to every 12 hours.

Step four involves increasing the dose of inhaled corticosteroids if control remains poor; higher doses may be necessary.

Alternative Treatment Pathways

The alternative pathway differs significantly as it does not include formoterol. Instead, short-acting beta agonists (SABAs), like salbutamol or fenoterol, are recommended for quick relief.

SABAs cannot replace inhaled corticosteroids; thus, they must always be used alongside them in any treatment plan.

Key Differences Between Treatment Pathways

In step two of the alternative pathway, only low-dose inhaled corticosteroids are maintained without LABA support since SABAs are not suitable for regular maintenance therapy.

Evaluation of Asthma Treatment Parameters

Key Parameters for Treatment Decision

The treatment decision for asthma patients is based on three parameters: daily symptoms, nocturnal awakenings, and pulmonary function.

These parameters help determine the appropriate stage to initiate treatment for the patient.

Patient Case Analysis

A patient with rare symptoms, no nocturnal awakenings, and normal or slightly reduced pulmonary function (FEV1 > 60%) may not require extensive treatment; they could start at stage one or two.

If a patient exhibits either nocturnal awakenings or few symptoms but has reduced pulmonary function (FEV1 < 60%), treatment should begin at stage three.

Severity Assessment in Patients

For patients with significant symptoms and nocturnal awakenings alongside reduced pulmonary function or recent exacerbations, treatment should commence at stages four or five. However, initiation at stage five is generally avoided.

Exacerbation within the last month indicates severe asthma requiring immediate attention and higher-stage intervention.

Staging Summary According to GINA Guidelines

Stages One and Two: Infrequent symptoms (<2 times/month) without risk factors; also applicable for mild cases with slight functional impairment (3–5 days/week).

Stage Three: Symptoms most days or frequent nocturnal awakenings with some reduction in lung function.

Stage Four: Daily symptoms and significant functional impairment; exacerbations noted in the past month indicate severe control issues.

Practical Application in Exam Scenarios

Understanding symptom frequency helps categorize severity effectively during examinations; e.g., daily symptoms suggest stage four while infrequent ones suggest stages one or two.

Understanding Asthma Control and Treatment Adjustments

Importance of Inhaled Corticosteroids

Long-term management of asthma must include inhaled corticosteroids; their absence indicates inadequate treatment strategy regardless of other medications like salbutamol being used intermittently.

Evaluating Asthma Severity Retrospectively

Asthma severity assessment relies on retrospective evaluation based on the level of treatment required to achieve control—mild asthma requires minimal intervention while severe cases necessitate more aggressive management strategies.

Classification Based on Control Levels

Controlled asthma corresponds to stages one and two; moderate asthma aligns with stages three or four, while uncontrolled conditions are classified as severe if they only respond to high-level interventions (stage C).

Factors Influencing Non-Controlled Asthma

Assessing Patient Adherence

Exacerbation of Asthma: Understanding and Management

Definition of Asthma Exacerbation

An asthma exacerbation is defined as a significant change in the patient's usual status that necessitates a modification in treatment. It can occur in patients with pre-existing conditions or as an initial manifestation of the disease.

It represents an acute worsening of bronchial asthma, requiring medical attention and potential changes to the treatment plan.

Treatment Priorities During Exacerbation

The primary focus during an exacerbation is bronchodilation, contrasting with maintenance therapy where inhaled corticosteroids are crucial for long-term management.

Patients may experience acute bronchial hyperresponsiveness, which can lead to severe outcomes such as desaturation or even death if not addressed promptly.

Assessing Severity of Exacerbations

Initial assessment involves determining the severity of the exacerbation, which can range from mild to nearly fatal. This classification helps guide treatment decisions.

A "nearly fatal" asthma attack may present with symptoms like confusion, lethargy, and silent chest (absence of wheezing), indicating severe hypoxemia.

Emergency Management Strategies

For critically ill patients, aggressive treatment is necessary. This includes administering short-acting beta agonists (SABAs) alongside anticholinergics like ipratropium.

Supplemental oxygen should be provided due to common hypoxemia in these cases, and preparation for intubation may be required for severely affected patients.

Differentiating Between Asthma Severity Levels

In emergency settings, distinguishing between mild/moderate and severe asthma is essential. If a patient appears stable and likely to improve post-treatment, they may be sent home; otherwise, hospitalization is warranted.

Key indicators of severe asthma include inability to complete sentences due to dyspnea, use of accessory muscles for breathing, diffuse wheezing across the thorax, tachycardia over 120 bpm, and low peak flow readings (<50% predicted).

Asthma Management Strategies

Severe Asthma Treatment Protocol

In cases of severe asthma, the use of salbutamol and ipratropium is recommended to maximize bronchodilation.

If non-invasive ventilation is being utilized, intravenous corticosteroids can be administered without interrupting nebulization.

Magnesium sulfate may be considered for refractory patients with hypoxemia or very low peak flow rates (below 25-30%).

High-dose inhaled corticosteroids are indicated for patients not previously on oral corticosteroids or those who did not respond well in past crises.

Identifying Mild to Moderate Asthma

Mild to moderate asthma is characterized by a patient who can complete sentences, has mild respiratory distress, and shows minimal muscle retraction.

Normal respiratory rate (20-30 breaths per minute), heart rate under 120 bpm, and peak flow greater than 50% indicate less severe asthma.

Initial treatment includes salbutamol or fenoterol; if ineffective, ipratropium may be added. Oxygen should maintain saturation between 93%-95%.

Outdated Treatments and Current Practices

Aminophylline and theophylline are no longer routinely used in asthma management due to their ineffectiveness.

Subcutaneous adrenaline is reserved for anaphylactic crises rather than asthma exacerbations.

Case Study: Patient Assessment

A case study discusses a 42-year-old male with worsening asthma symptoms despite using salbutamol at home.

The patient exhibits good general condition but prefers sitting; vital signs show normal respiratory rate and oxygen saturation at 95%.

Treatment Recommendations for Exacerbation

For this patient, four puffs of salbutamol every 20 minutes along with a course of oral prednisone (40 mg daily for 5–7 days) are advised.

Guidelines on Radiography and Corticosteroid Use

Recent guidelines suggest magnesium sulfate remains appropriate for refractory cases; however, it’s not contraindicated as previously thought.

Routine chest X-rays are unnecessary unless differential diagnosis is needed (e.g., pneumonia).

Importance of Inhaled Corticosteroids

Course Recap and Upcoming Events

Course Overview

The instructor reflects on the recently concluded intensive course, emphasizing its focus on essential content likely to appear in exams.

Encourages viewers to engage with the video by liking, subscribing, and following his Instagram for further inquiries.

Promotions and Opportunities

Announces upcoming courses starting July 1st, including promotional pricing for various programs such as "banco de questões" and "curso intensivo".

Highlights a specific course on electrocardiography ("estratégia Eletro") that is also available at a discount during the mid-year enrollment period.

Important Upcoming Class

Previews an exclusive class scheduled for next Friday at 19:00 focused on spirometry, covering asthma diagnosis and interpretation of spirometry curves.

Stresses the importance of this topic due to its frequent appearance in both practical and theoretical exams.

Audience Engagement

Thanks participants for their attendance and engagement throughout the session, expressing gratitude for their continued interest in clinical medicine.

Promotions and Study Materials

Special Offers

Introduces a special promotion offering 40% off on courses like r+ Turbo or Prime Class, along with exclusive bonuses.

Focused Study Material

Emphasizes that materials are tailored specifically for ENARI exam preparation, ensuring relevance to current testing standards.

Expert Guidance